{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:29:34Z","timestamp":1792783774028,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Basic Research Program of Shanxi Province","award":["202103021223438"],"award-info":[{"award-number":["202103021223438"]}]},{"name":"The Scientific Research Program of the Health Commission of Shanxi Province","award":["2021066"],"award-info":[{"award-number":["2021066"]}],"id":[{"id":"https:\/\/ror.org\/01nzpmv06","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the Science Technology Support Project for Overseas Scholars in Shanxi Province","award":["2022045"],"award-info":[{"award-number":["2022045"]}]},{"name":"The Shanxi Province Graduate Education Innovation Program","award":["2024SJ169"],"award-info":[{"award-number":["2024SJ169"]}]},{"name":"The Shanxi Province Graduate Education Innovation Program","award":["2023SJ145"],"award-info":[{"award-number":["2023SJ145"]}]},{"DOI":"10.13039\/501100001809","name":"The National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81870354"],"award-info":[{"award-number":["81870354"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Regional Cooperation Program of Shanxi Province, China","award":["202204041101038"],"award-info":[{"award-number":["202204041101038"]}]},{"name":"The Leading Talent Team Building Program of Shanxi Province, China","award":["202204051002010"],"award-info":[{"award-number":["202204051002010"]}]},{"name":"Construction and demonstration of molecular diagnosis and treatment platform for vascular diseases in Shanxi Province, China","award":["SCP-2023-17"],"award-info":[{"award-number":["SCP-2023-17"]}]},{"name":"Translational Medicine Engineering Research Center for Vascular Diseases of Shanxi Province, China","award":["2022017"],"award-info":[{"award-number":["2022017"]}]},{"name":"The Shanxi Provincial Science and Technology Department Centralized Guided Local Projects","award":["YDZJSX2021C026"],"award-info":[{"award-number":["YDZJSX2021C026"]}],"id":[{"id":"https:\/\/ror.org\/04qgr7x96","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770695"],"award-info":[{"award-number":["81770695"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"DOI":"10.1007\/s10753-025-02418-x","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T22:52:54Z","timestamp":1766530374000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["MIF Regulates the Th17\/Treg Ratio to Exacerbate Kidney Injury in Chronic Kidney Disease"],"prefix":"10.1007","volume":"49","author":[{"given":"Ruijing","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyi","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinshan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanlong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runze","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maolin","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjiu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijie","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglin","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,23]]},"reference":[{"issue":"5","key":"2418_CR1","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.kint.2019.07.012","volume":"96","author":"KJ Jager","year":"2019","unstructured":"Jager, K. J. et al. 2019. A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases. Kidney International 96(5):1048\u20131050. https:\/\/doi.org\/10.1016\/j.kint.2019.07.012","journal-title":"Kidney International"},{"issue":"4","key":"2418_CR2","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1093\/cvr\/cvaa258","volume":"117","author":"WY Ding","year":"2021","unstructured":"Ding, W. Y. et al. 2021. Pathophysiology of atrial fibrillation and chronic kidney disease. Cardiovascular Research 117(4):1046\u20131059. https:\/\/doi.org\/10.1093\/cvr\/cvaa258","journal-title":"Cardiovascular Research"},{"issue":"7","key":"2418_CR3","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41584-019-0238-2","volume":"15","author":"I Kang","year":"2019","unstructured":"Kang, I., and R. Bucala. 2019. The immunobiology of MIF: function, genetics and prospects for precision medicine. Nature Reviews Rheumatology 15(7):427\u2013437. https:\/\/doi.org\/10.1038\/s41584-019-0238-2","journal-title":"Nature Reviews Rheumatology"},{"issue":"3","key":"2418_CR4","doi-asserted-by":"publisher","first-page":"e79","DOI":"10.1159\/000145463","volume":"109","author":"HY Lan","year":"2008","unstructured":"Lan, H. Y. 2008. Role of macrophage migration Inhibition factor in kidney disease. Nephron. Experimental Nephrology 109(3):e79\u201383. https:\/\/doi.org\/10.1159\/000145463","journal-title":"Nephron. Experimental Nephrology"},{"issue":"3\u20134","key":"2418_CR5","doi-asserted-by":"publisher","first-page":"70","DOI":"10.2119\/molmed.2008.00109","volume":"15","author":"A Bruchfeld","year":"2009","unstructured":"Bruchfeld, A. et al. 2009. Elevated serum macrophage migration inhibitory factor (MIF) concentrations in chronic kidney disease (CKD) are associated with markers of oxidative stress and endothelial activation. Molecular Medicine 15(3\u20134):70\u201375. https:\/\/doi.org\/10.2119\/molmed.2008.00109","journal-title":"Molecular Medicine"},{"issue":"12","key":"2418_CR6","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1161\/CIRCULATIONAHA.107.729125","volume":"117","author":"A Zernecke","year":"2008","unstructured":"Zernecke, A., J. Bernhagen, and C. Weber. 2008. Macrophage migration inhibitory factor in cardiovascular disease. Circulation 117(12):1594\u20131602. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.107.729125","journal-title":"Circulation"},{"issue":"8","key":"2418_CR7","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1007\/s001340101022","volume":"27","author":"LE Lehmann","year":"2001","unstructured":"Lehmann, L. E. et al. 2001. Plasma levels of macrophage migration inhibitory factor are elevated in patients with severe sepsis. Intensive Care Medicine 27(8):1412\u20131415. https:\/\/doi.org\/10.1007\/s001340101022","journal-title":"Intensive Care Medicine"},{"issue":"9","key":"2418_CR8","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1080\/14728222.2019.1656718","volume":"23","author":"JB Bilsborrow","year":"2019","unstructured":"Bilsborrow, J. B. et al. 2019. Macrophage migration inhibitory factor (MIF) as a therapeutic target for rheumatoid arthritis and systemic lupus erythematosus. Expert Opinion on Therapeutic Targets 23(9):733\u2013744. https:\/\/doi.org\/10.1080\/14728222.2019.1656718","journal-title":"Expert Opinion on Therapeutic Targets"},{"issue":"8","key":"2418_CR9","doi-asserted-by":"publisher","first-page":"e0183162","DOI":"10.1371\/journal.pone.0183162","volume":"12","author":"J Baron-Stefaniak","year":"2017","unstructured":"Baron-Stefaniak, J. et al. 2017. Comparison of macrophage migration inhibitory factor and neutrophil gelatinase-associated lipocalin-2 to predict acute kidney injury after liver transplantation: An observational pilot study. PLoS One 12(8):e0183162. https:\/\/doi.org\/10.1371\/journal.pone.0183162","journal-title":"PLoS One"},{"key":"2418_CR10","doi-asserted-by":"publisher","unstructured":"Musial, K., and D. Zwolinska. 2021. Bone Morphogenetic Proteins (BMPs), Extracellular Matrix Metalloproteinases Inducer (EMMPRIN), and Macrophage Migration Inhibitory Factor (MIF): Usefulness in the Assessment of Tubular Dysfunction Related to Chronic Kidney Disease (CKD). Journal of Clinical Medicine, 10(21). https:\/\/doi.org\/10.3390\/jcm10214893","DOI":"10.3390\/jcm10214893"},{"issue":"1","key":"2418_CR11","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/path.4430","volume":"235","author":"X Peng","year":"2015","unstructured":"Peng, X. et al. 2015. IL-17A produced by both gammadelta T and Th17 cells promotes renal fibrosis via RANTES-mediated leukocyte infiltration after renal obstruction. The Journal of Pathology 235(1):79\u201389. https:\/\/doi.org\/10.1002\/path.4430","journal-title":"The Journal of Pathology"},{"issue":"5","key":"2418_CR12","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1016\/j.ajpath.2014.01.023","volume":"184","author":"AJ Chan","year":"2014","unstructured":"Chan, A. J. et al. 2014. Innate IL-17A-producing leukocytes promote acute kidney injury via inflammasome and Toll-like receptor activation. American Journal of Pathology 184(5):1411\u20131418. https:\/\/doi.org\/10.1016\/j.ajpath.2014.01.023","journal-title":"American Journal of Pathology"},{"issue":"5","key":"2418_CR13","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1161\/HYPERTENSIONAHA.119.14546","volume":"75","author":"T Song","year":"2020","unstructured":"Song, T. et al. 2020. Mesenchymal stem Cell-Derived extracellular vesicles induce regulatory T cells to ameliorate chronic kidney injury. Hypertension 75(5):1223\u20131232. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.119.14546","journal-title":"Hypertension"},{"key":"2418_CR14","doi-asserted-by":"publisher","first-page":"4977","DOI":"10.2147\/JIR.S424911","volume":"16","author":"R Zhang","year":"2023","unstructured":"Zhang, R. et al. 2023. Identification of cell-Cell communications by Single-Cell RNA sequencing in end stage renal disease provides new insights into immune cell heterogeneity. J Inflamm Res 16:4977\u20135000. https:\/\/doi.org\/10.2147\/JIR.S424911","journal-title":"J Inflamm Res"},{"issue":"7970","key":"2418_CR15","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41586-023-05769-3","volume":"619","author":"BB Lake","year":"2023","unstructured":"Lake, B. B. et al. 2023. An atlas of healthy and injured cell States and niches in the human kidney. Nature 619(7970):585\u2013594. https:\/\/doi.org\/10.1038\/s41586-023-05769-3","journal-title":"Nature"},{"key":"2418_CR16","doi-asserted-by":"publisher","unstructured":"KidneyDisease:Improving Global Outcomes, C, and K.D.W.G. 2024. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney International, 105(4S):S117-S314. https:\/\/doi.org\/10.1016\/j.kint.2023.10.018","DOI":"10.1016\/j.kint.2023.10.018"},{"issue":"4","key":"2418_CR17","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1055\/s-0039-1677803","volume":"119","author":"D Sinitski","year":"2019","unstructured":"Sinitski, D. et al. 2019. Macrophage migration inhibitory factor (MIF)-Based therapeutic concepts in atherosclerosis and inflammation. Thrombosis and Haemostasis 119(4):553\u2013566. https:\/\/doi.org\/10.1055\/s-0039-1677803","journal-title":"Thrombosis and Haemostasis"},{"issue":"1","key":"2418_CR18","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1159\/000153601","volume":"36","author":"M Willcox","year":"1986","unstructured":"Willcox, M., G. Beckman, and L. Beckman. 1986. Serum protein polymorphisms in a Liberian population. Human Heredity 36(1):54\u201357. https:\/\/doi.org\/10.1159\/000153601","journal-title":"Hum Hered"},{"key":"2418_CR19","doi-asserted-by":"publisher","first-page":"107555","DOI":"10.1016\/j.intimp.2021.107555","volume":"96","author":"Y Liu","year":"2021","unstructured":"Liu, Y. et al. 2021. MIF inhibitor ISO-1 alleviates severe acute pancreatitis-associated acute kidney injury by suppressing the NLRP3 inflammasome signaling pathway. International Immunopharmacology 96:107555. https:\/\/doi.org\/10.1016\/j.intimp.2021.107555","journal-title":"International Immunopharmacology"},{"issue":"6","key":"2418_CR20","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1681\/ASN.2015020149","volume":"27","author":"S Djudjaj","year":"2016","unstructured":"Djudjaj, S. et al. 2016. Macrophage migration inhibitory factor mediates proliferative GN via CD74. Journal of the American Society of Nephrology 27(6):1650\u20131664. https:\/\/doi.org\/10.1681\/ASN.2015020149","journal-title":"Journal of the American Society of Nephrology"},{"issue":"8","key":"2418_CR21","doi-asserted-by":"publisher","first-page":"5687","DOI":"10.4049\/jimmunol.177.8.5687","volume":"177","author":"AY Hoi","year":"2006","unstructured":"Hoi, A. Y. et al. 2006. Macrophage migration inhibitory factor deficiency attenuates macrophage recruitment, glomerulonephritis, and lethality in MRL\/lpr mice. The Journal of Immunology 177(8):5687\u20135696. https:\/\/doi.org\/10.4049\/jimmunol.177.8.5687","journal-title":"The Journal of Immunology"},{"key":"2418_CR22","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.3389\/fimmu.2019.02229","volume":"10","author":"Y Tu","year":"2019","unstructured":"Tu, Y. et al. 2019. MiRNA regulation of MIF in SLE and Attenuation of murine lupus nephritis with miR-654. Frontiers in Immunology 10:2229. https:\/\/doi.org\/10.3389\/fimmu.2019.02229","journal-title":"Frontiers in Immunology"},{"issue":"2","key":"2418_CR23","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1681\/ASN.2008020194","volume":"20","author":"MD Sanchez-Nino","year":"2009","unstructured":"Sanchez-Nino, M. D. et al. 2009. The MIF receptor CD74 in diabetic podocyte injury. Journal of the American Society of Nephrology 20(2):353\u2013362. https:\/\/doi.org\/10.1681\/ASN.2008020194","journal-title":"Journal of the American Society of Nephrology"},{"issue":"6866","key":"2418_CR24","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1038\/414920a","volume":"414","author":"T Roger","year":"2001","unstructured":"Roger, T. et al. 2001. MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature 414(6866):920\u2013924. https:\/\/doi.org\/10.1038\/414920a","journal-title":"Nature"},{"issue":"2","key":"2418_CR25","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.4049\/jimmunol.0904104","volume":"185","author":"Q Cheng","year":"2010","unstructured":"Cheng, Q. et al. 2010. Macrophage migration inhibitory factor increases leukocyte-endothelial interactions in human endothelial cells via promotion of expression of adhesion molecules. The Journal of Immunology 185(2):1238\u20131247. https:\/\/doi.org\/10.4049\/jimmunol.0904104","journal-title":"The Journal of Immunology"},{"issue":"12","key":"2418_CR26","doi-asserted-by":"publisher","first-page":"3590","DOI":"10.1681\/ASN.2017020190","volume":"28","author":"S Djudjaj","year":"2017","unstructured":"Djudjaj, S. et al. 2017. Macrophage migration inhibitory factor limits renal inflammation and fibrosis by counteracting tubular cell cycle arrest. Journal of the American Society of Nephrology 28(12):3590\u20133604. https:\/\/doi.org\/10.1681\/ASN.2017020190","journal-title":"Journal of the American Society of Nephrology"},{"key":"2418_CR27","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.cyto.2018.11.014","volume":"115","author":"LA Hernandez-Palma","year":"2019","unstructured":"Hernandez-Palma, L. A. et al. 2019. Functional MIF promoter haplotypes modulate Th17-related cytokine expression in peripheral blood mononuclear cells from control subjects and rheumatoid arthritis patients. Cytokine 115:89\u201396. https:\/\/doi.org\/10.1016\/j.cyto.2018.11.014","journal-title":"Cytokine"},{"key":"2418_CR28","doi-asserted-by":"publisher","first-page":"110494","DOI":"10.1016\/j.intimp.2023.110494","volume":"121","author":"Z Liu","year":"2023","unstructured":"Liu, Z. et al. 2023. MIF promotes Th17 cell differentiation in hashimoto\u2019s thyroiditis by binding HVEM and activating NF-kappaB signaling pathway. International Immunopharmacology 121:110494. https:\/\/doi.org\/10.1016\/j.intimp.2023.110494","journal-title":"International Immunopharmacology"},{"key":"2418_CR29","doi-asserted-by":"publisher","first-page":"199316","DOI":"10.1016\/j.virusres.2024.199316","volume":"341","author":"R Xu","year":"2024","unstructured":"Xu, R. et al. 2024. Sulforaphane effectively inhibits HBV by altering Treg\/Th17 immune balance and the MIF-macrophages polarizing axis in vitro and in vivo. Virus Research 341:199316. https:\/\/doi.org\/10.1016\/j.virusres.2024.199316","journal-title":"Virus Research"},{"key":"2418_CR30","doi-asserted-by":"publisher","unstructured":"Duraes, do V. 2020. Immune cell landscaping reveals a protective role for regulatory T cells during kidney injury and fibrosis. JCI Insight 5(3). https:\/\/doi.org\/10.1172\/jci.insight.130651","DOI":"10.1172\/jci.insight.130651"},{"issue":"8","key":"2418_CR31","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1681\/ASN.2008111160","volume":"20","author":"GR Kinsey","year":"2009","unstructured":"Kinsey, G. R. et al. 2009. Regulatory T cells suppress innate immunity in kidney ischemia-reperfusion injury. Journal of the American Society of Nephrology 20(8):1744\u20131753. https:\/\/doi.org\/10.1681\/ASN.2008111160","journal-title":"Journal of the American Society of Nephrology"},{"issue":"20","key":"2418_CR32","doi-asserted-by":"publisher","first-page":"e10748","DOI":"10.1097\/MD.0000000000010748","volume":"97","author":"X Zhu","year":"2018","unstructured":"Zhu, X. et al. 2018. Correlation of increased Th17\/Treg cell ratio with Endoplasmic reticulum stress in chronic kidney disease. Medicine (Baltimore) 97(20):e10748. https:\/\/doi.org\/10.1097\/MD.0000000000010748","journal-title":"Medicine (Baltimore)"},{"key":"2418_CR33","doi-asserted-by":"publisher","first-page":"1113560","DOI":"10.3389\/fimmu.2023.1113560","volume":"14","author":"DL Huang","year":"2023","unstructured":"Huang, D. L. et al. 2023. The Immunomodulation role of Th17 and Treg in renal transplantation. Frontiers in Immunology 14:1113560. https:\/\/doi.org\/10.3389\/fimmu.2023.1113560","journal-title":"Frontiers in Immunology"},{"key":"2418_CR34","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.3389\/fimmu.2020.01027","volume":"11","author":"J Shan","year":"2020","unstructured":"Shan, J., H. Jin, and Y. Xu. 2020. T Cell Metabolism: A new perspective on Th17\/Treg cell imbalance in systemic lupus erythematosus. Frontiers in Immunology 11:1027. https:\/\/doi.org\/10.3389\/fimmu.2020.01027","journal-title":"Frontiers in Immunology"},{"key":"2418_CR35","doi-asserted-by":"publisher","unstructured":"Zhou, X.et al. 2022. Th17\/Regulatory T-Cell imbalance and acute kidney injury in patients with sepsis. Journal of Clinical Medicine 11(14). https:\/\/doi.org\/10.3390\/jcm11144027","DOI":"10.3390\/jcm11144027"},{"issue":"5","key":"2418_CR36","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1002\/2211-5463.13147","volume":"11","author":"D Wang","year":"2021","unstructured":"Wang, D. et al. 2021. Dapagliflozin reverses the imbalance of T helper 17 and T regulatory cells by inhibiting SGK1 in a mouse model of diabetic kidney disease. FEBS Open Bio 11(5):1395\u20131405. https:\/\/doi.org\/10.1002\/2211-5463.13147","journal-title":"FEBS Open Bio"},{"issue":"1","key":"2418_CR37","doi-asserted-by":"publisher","first-page":"e1040217","DOI":"10.1080\/2162402X.2015.1040217","volume":"5","author":"N. Obermajer","year":"2016","unstructured":"Obermajer,N., and M. H. Dahlke. 2016. (Compl)Ex-Th17-T(reg) cell inter-relationship. Oncoimmunology 5(1):e1040217. https:\/\/doi.org\/10.1080\/2162402X.2015.1040217","journal-title":"Oncoimmunology"},{"issue":"1","key":"2418_CR38","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1189\/jlb.1RU0114-010RR","volume":"96","author":"R Du","year":"2014","unstructured":"Du, R. et al. 2014. IL-17\u2009+\u2009Foxp3\u2009+\u2009T cells: An intermediate differentiation stage between Th17 cells And regulatory T cells. Journal of Leukocyte Biology 96(1):39\u201348. https:\/\/doi.org\/10.1189\/jlb.1RU0114-010RR","journal-title":"Journal of Leukocyte Biology"},{"issue":"1","key":"2418_CR39","doi-asserted-by":"publisher","first-page":"527","DOI":"10.4049\/jimmunol.1001767","volume":"186","author":"L Leng","year":"2011","unstructured":"Leng, L. et al. 2011. A small-molecule macrophage migration inhibitory factor antagonist protects against glomerulonephritis in lupus-prone NZB\/NZW F1 and MRL\/lpr mice. The Journal of Immunology 186(1):527\u2013538. https:\/\/doi.org\/10.4049\/jimmunol.1001767","journal-title":"The Journal of Immunology"},{"issue":"6","key":"2418_CR40","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1007\/s10753-014-9934-x","volume":"37","author":"Z Wang","year":"2014","unstructured":"Wang, Z. et al. 2014. Inhibition of macrophage migration inhibitory factor reduces diabetic nephropathy in type II diabetes mice. Inflammation 37(6):2020\u20132029. https:\/\/doi.org\/10.1007\/s10753-014-9934-x","journal-title":"Inflammation"},{"issue":"2\u20133","key":"2418_CR41","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.micpath.2006.06.001","volume":"41","author":"H Sashinami","year":"2006","unstructured":"Sashinami, H. et al. 2006. The role of macrophage migration inhibitory factor in lethal Listeria monocytogenes infection in mice. Microbial Pathogenesis 41(2\u20133):111\u2013118. https:\/\/doi.org\/10.1016\/j.micpath.2006.06.001","journal-title":"Microbial Pathogenesis"},{"issue":"21","key":"2418_CR42","doi-asserted-by":"publisher","first-page":"13681","DOI":"10.1073\/pnas.212488699","volume":"99","author":"H Koebernick","year":"2002","unstructured":"Koebernick,H. et al. 2002. Macrophage migration inhibitory factor (MIF) plays a pivotal role in immunity against Salmonella typhimurium. Proceedings of the National Academy of Sciences of the United States of America 99(21):13681\u201313686. https:\/\/doi.org\/10.1073\/pnas.212488699","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"3","key":"2418_CR43","doi-asserted-by":"publisher","first-page":"152357","DOI":"10.1016\/j.imbio.2023.152357","volume":"228","author":"PTM Ferreira","year":"2023","unstructured":"Ferreira, P. T. M. et al. 2023. Macrophage migration inhibitory factor contributes to drive phenotypic and functional macrophages activation in response to Toxoplasma gondii infection. Immunobiology 228(3):152357. https:\/\/doi.org\/10.1016\/j.imbio.2023.152357","journal-title":"Immunobiology"},{"key":"2418_CR44","doi-asserted-by":"publisher","first-page":"22488","DOI":"10.1038\/srep22488","volume":"6","author":"X Xu","year":"2016","unstructured":"Xu, X. et al. 2016. Macrophage migration inhibitory factor (MIF) deficiency exacerbates Aging-Induced cardiac remodeling and dysfunction despite improved inflammation: Role of autophagy regulation. Scientific Reports 6:22488. https:\/\/doi.org\/10.1038\/srep22488","journal-title":"Scientific Reports"},{"issue":"1\u20132","key":"2418_CR45","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s12026-012-8281-y","volume":"52","author":"I Stojanovic","year":"2012","unstructured":"Stojanovic, I., T. Saksida, and S. Stosic-Grujicic. 2012. Beta cell function: The role of macrophage migration inhibitory factor. Immunologic Research 52(1\u20132):81\u201388. https:\/\/doi.org\/10.1007\/s12026-012-8281-y","journal-title":"Immunologic Research"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-025-02418-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-025-02418-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-025-02418-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:30:20Z","timestamp":1767659420000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-025-02418-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,23]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2418"],"URL":"https:\/\/doi.org\/10.1007\/s10753-025-02418-x","relation":{},"ISSN":["1573-2576"],"issn-type":[{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,23]]},"assertion":[{"value":"16 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were conducted in compliance with the National Institutes of Health guidelines and approved by the Ethics Committee of the Second Hospital of Shanxi Medical University (DW2023053). This study involving human samples was conducted in accordance with the Declaration of Helsinki and were approved by the Ethics Committee of the Second Hospital of Shanxi Medical University (No.2023098). All subjects participating in the study gave informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"The authors affirm that human research participants provided informed consent for publication of the images in Figs.\u00a02 and 5 and Supplementary Fig.\u00a01.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trial Number"}}],"article-number":"15"}}